My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 609

    1.

    A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

    Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

    Diabetes Care. 2005 Jul;28(7):1568-73.PMID: 15983302 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

    Diabetes Care. 2009 Jul;32(7):1170-6. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944. PMID: 19389820 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

    Diabetes Care. 2004 Jul;27(7):1554-8.PMID: 15220227 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

    Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

    Diabetes Care. 2003 Sep;26(9):2598-603.PMID: 12941725 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

    Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group.

    Diabet Med. 2006 Feb;23(2):141-7.PMID: 16433711 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

    Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

    Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

    Diabetes Technol Ther. 2005 Aug;7(4):587-96.PMID: 16120030 [PubMed - indexed for MEDLINE]Related articles

    8.

    Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

    Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

    Diabetes Technol Ther. 2007 Aug;9(4):339-47.PMID: 17705689 [PubMed - indexed for MEDLINE]Related articles

    9.

    Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.

    EQuality1 Study Group--Evaluation of QUALITY of Life and Costs in Diabetes Type 1, Nicolucci A, Maione A, Franciosi M, Amoretti R, Busetto E, Capani F, Bruttomesso D, Di Bartolo P, Girelli A, Leonetti F, Morviducci L, Ponzi P, Vitacolonna E.

    Diabet Med. 2008 Feb;25(2):213-20. Epub 2008 Jan 14.PMID: 18201210 [PubMed - indexed for MEDLINE]Related articles

    10.

    Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus.

    Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J.

    Pediatr Diabetes. 2008 Oct;9(5):472-9. Epub 2008 Aug 20.PMID: 18721168 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection.

    Tsui E, Barnie A, Ross S, Parkes R, Zinman B.

    Diabetes Care. 2001 Oct;24(10):1722-7.PMID: 11574432 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes.

    Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV.

    Diabetes Care. 1999 Nov;22(11):1779-84.PMID: 10546007 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Comparison between continuous subcutaneous insulin infusion and multiple insulin injection therapy in type 1 diabetes mellitus: 18-month follow-up.

    Hissa MN, Hissa AS, Bruin VM, Fredrickson LP.

    Endocr Pract. 2002 Nov-Dec;8(6):411-6.PMID: 15251830 [PubMed - indexed for MEDLINE]Related articles

    14.

    Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

    Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A.

    Diabetologia. 2008 Jun;51(6):941-51. Epub 2008 Mar 20. Review.PMID: 18351320 [PubMed - indexed for MEDLINE]Related articles

    15.

    A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.

    Abaci A, Atas A, Unuvar T, Demir K, Bober E, Büyükgebiz A.

    J Pediatr Endocrinol Metab. 2009 Jun;22(6):539-45.PMID: 19694201 [PubMed - indexed for MEDLINE]Related articles

    16.

    A quality-of-life assessment of intensive insulin therapy using insulin lispro switched from short-acting insulin and measured by an ITR-QOL questionnaire: a prospective comparison of multiple daily insulin injections and continuous subcutaneous insulin infusion.

    Kamoi K, Miyakoshi M, Maruyama R.

    Diabetes Res Clin Pract. 2004 Apr;64(1):19-25.PMID: 15036823 [PubMed - indexed for MEDLINE]Related articles

    17.

    Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service.

    Giménez M, Conget I, Jansà M, Vidal M, Chiganer G, Levy I.

    Diabet Med. 2007 Dec;24(12):1419-23. Epub 2007 Oct 17.PMID: 17941861 [PubMed - indexed for MEDLINE]Related articles

    18.

    Continuous subcutaneous insulin infusion therapy: effects on quality of life.

    Scheidegger U, Allemann S, Scheidegger K, Diem P.

    Swiss Med Wkly. 2007 Aug 25;137(33-34):476-82.PMID: 17990132 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.

    Pickup JC, Renard E.

    Diabetes Care. 2008 Feb;31 Suppl 2:S140-5. Review.PMID: 18227475 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Switch to multiple daily injections with insulin glargine and insulin lispro from continuous subcutaneous insulin infusion with insulin lispro: a randomized, open-label study using a continuous glucose monitoring system.

    Bode BW, Steed RD, Schleusener DS, Strange P.

    Endocr Pract. 2005 May-Jun;11(3):157-64.PMID: 16239201 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity